United Therapeutics
(NASDAQ) UTHR
United Therapeutics Financials at a Glance
Market Cap
$23.03B
Revenue (TTM)
$3.17B
Net Income (TTM)
$1.29B
EPS (TTM)
$27.09
P/E Ratio
20.03
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Price
$544.60
Volume
20,979
Open
$548.59
Price
$544.60
Volume
20,979
Open
$548.59
Previous Close
$544.60
Daily Range
$539.73 - $549.38
52-Week Range
$272.12 - $609.35
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Price
$544.60
Volume
20,979
Open
$548.59
Previous Close
$544.60
Daily Range
$539.73 - $549.38
52-Week Range
$272.12 - $609.35
Estimated Earnings Date
Jul 29, 2026
UTHR News
Best Biotech ETFs to Buy in 2026
UTHR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout United Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
1,400
CEO
Martine A. Rothblatt, PhD, MBA
Website
www.unither.comHeadquarters
Silver Spring, MD 20910, US
UTHR Financials
Key Financial Metrics (TTM)
Gross Margin
86.58%
Operating Margin
45.34%
Net Income Margin
40.61%
Return on Equity
19.24%
Return on Capital
21.38%
Return on Assets
19.17%
Earnings Yield
4.99%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.03B
Shares Outstanding
42.45M
Volume
20.98K
Avg. Volume
543.83K
Financials (TTM)
Gross Profit
$2.74B
Operating Income
$1.44B
EBITDA
$1.71B
Operating Cash Flow
$1.56B
Capital Expenditure
-$546.40M
Free Cash Flow
$1.02B
Cash & ST Invst.
$2.15B
Total Debt
$0.00
United Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$781.50M
-1.6%
Gross Profit
$648.10M
-7.7%
Gross Margin
82.93%
N/A
Market Cap
$23.03B
N/A
Market Cap/Employee
$17.65M
N/A
Employees
1,305
N/A
Net Income
$274.90M
-14.7%
EBITDA
$343.90M
-21.3%
Quarterly Fundamentals
Total Cash
$2.15B
-35.2%
Total Debt
$0.00
-100.0%
Accounts Receivable
$312.00M
-3.1%
Inventory
$178.30M
+7.8%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
19.17%
N/A
Return on Invested Capital
23.50%
N/A
Free Cash Flow
$362.50M
-6.2%
Operating Cash Flow
$463.30M
+0.5%